Minimally invasive surgeries have involved the use of multiple small incisions to perform a surgical procedure instead of one larger opening. The small incisions have reduced patient discomfort and improved recovery times. The small incisions have also limited the visibility of internal organs, tissue, and other matter.
Endoscopes have been inserted in one or more of the incisions to make it easier for clinicians to see internal organs, tissue, and other matter inside the body during surgery. These endoscopes have included a camera with an optical and/or digital zoom capability that is coupled to a display showing the magnified view of organs, tissue, and matter inside the body as captured by the camera. Existing endoscopes and displays, especially those used in surgical robotic systems, have had a limited ability to identify conditions or objects that are within the field of view of the camera but are not fully visible within the spectrum shown on the display. For example, existing minimally invasive and robotic surgical tools, including but not limited to endoscopes and displays, have had a limited, if any, ability to identify blood perfusion during a minimally invasive surgical procedure. In order to identify blood perfusion, many procedures involved adding taggants to the patient's blood stream.
In view thereof, there is a need for identifying a greater range of possible conditions or objects that are within the field of view of a surgical camera but are not fully visible within the spectrum shown on the display during surgery.
The present disclosure relates to video imaging techniques of target surgical sites, in vivo, during a surgical procedure, for detecting gradual changes in perfusion of tissue at the target surgical site.
In an aspect of the present disclosure, an augmented reality surgical system is provided. The system includes an endoscope configured to capture an image of a region of interest of a patient and an electrocardiogram (ECG) device configured to record electrical activity of a heart of the patient. The system also includes a controller configured to receive the image and apply at least one image processing filter to the image to generate an augmented image. The image processing filter includes a decomposition filter configured to decompose the image into a plurality of frequency bands, a temporal filter that is configured to be applied to the plurality of frequency bands to generate a plurality of temporally filtered bands, an adder configured to add each band in the plurality of frequency bands to a corresponding band in the plurality of temporally filtered bands to generate a plurality of augmented bands, a reconstruction filter configured to generate an augmented image by collapsing the plurality of augmented bands, and an ECG filter configured to generate the ECG filtered augmented image based on the augmented image and the electrical activity. The ECG filtered augmented image of the patient is then displayed to a user.
The image capture device may capture a video having a plurality of image frames and the controller applies the at least one image processing filter to each image frame of the plurality of image frames.
The temporal filter isolates at least one frequency band from the plurality of frequency bands to generate the plurality of temporally filtered bands. The plurality of temporally filtered bands are amplified by an amplifier before each band in the plurality of frequency bands is added to a corresponding band in the plurality of temporally filtered bands to generate a plurality of augmented bands.
The ECG filter may generate a baseline time varying signal. The ECG filter may average the baseline time varying amplified color and remove the averaged baseline time varying amplified color from the augmented image.
In some aspects, the endoscope includes an illumination device or optical fiber light guide. The endoscope may emit light having a wavelength that is selectively absorbed or reflected by arterial blood and/or venous blood.
In another aspect of the present disclosure, a method for generating an electrocardiogram (ECG) filtered augmented image is provided. The method includes capturing at least one image using an endoscope and recording electrical activity of a heart of the patient using an ECG device. The at least one image is decomposed to generate a plurality of frequency bands. A temporal filter is applied to the plurality of frequency bands to generate a plurality of temporally filtered bands. Each band in the plurality of frequency bands is added to a corresponding band in the plurality of temporally filtered bands to generate a plurality of augmented bands. The plurality of augmented bands is collapsed to generate an augmented image. The augmented image and the electrical activity are used to generate the ECG filtered augmented image which is displayed on a display.
At least one frequency band is isolated from the plurality of frequency bands. The temporally filtered bands may be amplified before adding each band in the plurality of frequency bands to a corresponding band in the plurality of temporally filtered bands to generate a plurality of augmented bands.
A baseline time varying amplified color is generated which may then be averaged. The averaged baseline time varying amplified color is removed from the augmented image to generate the ECG filtered augmented image.
In some aspects, light having a wavelength that is selectively absorbed or reflected by arterial blood or venous blood is emitted onto the tissue.
The above and other aspects, features, and advantages of the present disclosure will become more apparent in light of the following detailed description when taken in conjunction with the accompanying drawings in which:
Image data captured from a surgical camera during a surgical procedure may be analyzed to identify additional not readily human perceivable properties of objects within the camera field of view that may not be apparent to people viewing the camera image displayed on a screen. Various image processing technologies may be applied to this image data to identify different conditions in the patient. For example, Eulerian image amplification techniques may be used to identify small wavelength or “color” changes of light in different parts of a captured image. These changes may be further analyzed to identify re-perfusion, arterial flow, and/or vessel types.
Eulerian image amplification may also be used to make motion or movement between image frames more visible to a clinician. In some instances changes in a measured intensity of predetermined wavelengths of light between different image frames may be presented to a clinician to make the clinician more aware of the motion of particular objects of interest (such as blood).
Hyper-spectral image analysis may be used to identify subtle changes in small areas within the range of view that may be invisible or otherwise difficult for the human eye to discern. These hyper-spectral image analysis techniques may be combined with Eulerian image amplification to identify a specific set of changes in these areas.
One or more of Eulerian image amplification, image algebra, hyper-spectral image analysis, and filtering technologies may be included as part of an imaging system. These technologies may enable the imaging system to provide additional information about unapparent conditions and objects within a camera's field of view and enhance surgical outcomes. This additional information may include, but is not limited to, identifying tissue perfusion, locating arteries of specific sizes (such as larger arteries), verifying an effectiveness of vessel sealing, identifying a heat signature of abnormal tissue, verifying desired object motion (such as a lack of movement in edges of dead tissue or verifying proper flow after resection), distinguishing between similar looking objects (such as between the ureter, inferior mesenteric artery, and/or surrounding blood), and detecting small leaks (such as leaks that may occur after an anastomosis).
One or more of these technologies may be included as part of an imaging system in a surgical robotic system to provide a clinician with additional information in real time about unapparent conditions and objects within an endoscope's field of view. This may enable the clinician to quickly identify, avoid, and/or correct undesirable situations and conditions during surgery. For example, a clinician may be able to verify during surgery that vessels have been properly sealed, that blood is properly flowing, that there are no air leaks after an anastomosis, and/or that diseased tissue has been removed. The clinician may then be able to correct these issues if needed during the surgery. A clinician may also be able to identify delicate or critical objects in the body that the surgical instruments should avoid contacting or handle with extra care, such as larger arteries or the ureter.
Meanwhile, an electrocardiogram (ECG) device is generally used to measure the electrical activity of a patient's heart. The electrical activity corresponds to the cyclic change of blood flow through the body. There is a consistent correlation between the electrical activity and the variation in blood flow at a target region.
The present disclosure is directed to systems and methods for providing an augmented image in real time to a clinician during a surgical procedure. The systems and methods described herein apply image processing filters to a captured image to provide an augmented or enhanced image to a clinician via a display. In some embodiments, the systems and methods permit video capture during a surgical procedure. The captured video is processed in real time or near real time and then displayed to the clinician as an augmented image. The image processing filters are applied to each frame of the captured video. Providing the augmented image or video to the clinician permits the clinician to identify and address potential adverse physiologic conditions thereby reducing the need for additional surgical procedures as well as ensuring the effectiveness of the original surgical procedure.
The embodiments described herein enable a clinician to identify and filter out the cyclical change in blood flow, i.e., resulting from the propagation of flow from the heart, in the augmented image to permit a clinician to determine if there is an abnormal change in blood perfusion. The clinician may also determine if the change in blood perfusion is within the arterial blood flow or the venous blood flow. The embodiments described herein use a concept known as ECG gating in which data is acquired in relation to the ECG identified cardiac cycle. Using ECG gating to time average the color amplification of a region of interest, permits subtle changes in tissue to be readily and immediately observed without adding taggants or making modifications to existing endoscopes. The systems described herein permit clinicians to see and understand clinically significant situations such as blood flow obstructions from clamping of tissue.
Turning to
Prior to insertion of the elongated shaft 12 into the cannula and the abdominal cavity, the surgeon adjusts the elongated shaft 12 into a pre-bent configuration to obtain an optimal viewing window. The elongated shaft 12 is then returned to the original straight configuration. Once inserted into the abdominal cavity, the elongated shaft assumes the pre-bent configuration. In one embodiment, the elongated shaft 12 assumes the pre-bent configuration in response to temperature within the body cavity. In an alternate embodiment, the elongated shaft 12 responds to an electrical signal from a control unit.
With continued reference to
The image capturing device 22 and illumination device 24 can be disposed in varying configurations along the distal portion 16 of the elongated shaft 12. Based on the location of the image capturing device 22, the elongated shaft 12 is pre-bent to provide the desired location as well as optimal angle for the surgeon. This variation in the pre-bent configuration is determined by varying the length of the bent portion (i.e. the distal portion) and the angle of the bend 26.
Turning to
Turning now to
The illumination device 24 of
Turning to
A sensor array 108 of system 100 provides information concerning the surgical environment to the controller 102. For instance, sensor array 108 includes biometric sensors capable of obtaining biometric data of a patient such as, pulse, temperature, blood pressure, blood oxygen levels, heart rhythm, etc. Sensor array 108 may also include hyper-spectral sensors to perform hyper-spectral imaging. Sensor array 108 may be incorporated in endoscope 10 or endoscope 30 or sensor array 108 may be provided as a separate standalone unit.
An ECG device 110 of system 100 provides an ECG or electrical activity signals of the heart of the patient to the controller 102. A display 112 of system 100, displays augmented images to a clinician during a surgical procedure. In some embodiments, the controller 102 may communicate with a central server (not shown) via a wireless or wired connection. The central server may store images of a patient or multiple patients that may be obtained using x-ray, a computed tomography scan, or magnetic resonance imaging.
Turning to
After the frame is subjected to the decomposition filter 118, a temporal filter 120 is applied to all the frequency bands S1 to Sato generate temporally filtered bands ST1 to STN. The temporal filter 120 is a bandpass filter that is used to extract one or more desired frequency bands. For example, if the clinician knows the patient's pulse, the clinician can set the bandpass frequency of the temporal filter 120, using a user interface (not shown), to magnify the frequency band that corresponds to the patient's pulse. In other words, the bandpass filter is set to a narrow range that includes the patient's pulse and applied to all the frequency bands S1 to SN. Only the frequency band that corresponds to the set range of the bandpass filter will be isolated or passed through. In an embodiment, the bandpass frequency of the temporal filter 120 may be set automatically by system 100 based on the patient's pulse being measured by a pulse sensor, included in sensor array 108, and transmitted to temporal filter 120.
All of the temporally filtered bands ST1 to STN are individually amplified by an amplifier having a gain “α”. Because the temporal filter 120 isolates or passes through a desired frequency band of bands S1 to SN, only the desired frequency band of bands S1 to SN gets amplified. The amplified temporally filtered bands ST1 to STN are then added, by adder 121, to the original frequency bands S1 to SN to generate augmented bands S′1 to S′N. Each frame of the video is then reconstructed using a reconstruction filter 122 by collapsing augmented bands S′1 to S′N to generate an augmented frame. All the augmented frames are combined to produce the augmented video. The augmented video that is shown to the clinician includes a portion that is magnified, i.e., the portion that corresponds to the desired frequency band, to enable the clinician to easily identify such portion.
In some embodiments, instead of using an amplifier to amplify the isolated temporally filtered band, the image processing filter 116A may highlight the temporally filtered band using one or more colors before reconstructing the video. Using an enhanced color for a desired portion of the patient, e.g., a vessel or nerve, may make it easier for the clinician to identify the location of such portion.
Turning to
The image processing performed by image processing filter 116 may be combined with the specific light wavelengths emitted by illumination device 24 or optical fiber light guide 52, e.g., 660 nm and 940 nm, to determine if there is an abnormal blood flow in the arterial system or the venous system. Specifically, the illumination device 24 or optical fiber light guide 52 may emit light having a wavelength that selectively is absorbed or reflected by arterial blood. The received images and the ECG data or signals are processed by the image processing filter 116 to check for abnormalities in the arterial blood flow. The same procedure would apply to venous blood except that the illumination device 24 or optical fiber light guide 52 would emit light having a wavelength that isolates venous blood.
The above-described embodiments may also be configured to work with robotic surgical systems and what is commonly referred to as “Telerobotic surgery.” Such systems employ various robotic elements to assist the clinician in the operating theater and allow remote operation (or partial remote operation) of surgical instrumentation. Various robotic arms, gears, cams, pulleys, electric and mechanical motors, etc. may be employed for this purpose and may be designed with a robotic surgical system to assist the clinician during the course of an operation or treatment. Such robotic systems may include, remotely steerable systems, flexible surgical systems, remotely flexible surgical systems, remotely articulating surgical systems, wireless surgical systems, modular or selectively configurable remotely operated surgical systems, etc.
As shown in
The robotic arms 206 of the surgical system 200 are typically coupled to a pair of master handles 208 by a controller 210. Controller 210 may be integrated with the console 202 or provided as a standalone device within the operating theater. The handles 206 can be moved by the clinician to produce a corresponding movement of the working ends of any type of surgical instrument 204 (e.g., probe, end effectors, graspers, knifes, scissors, etc.) attached to the robotic arms 206. For example, surgical instrument 204 may be a probe, e.g., endoscope, that includes an image capture device. The probe is inserted into a patient in order to capture an image of a region of interest inside the patient during a surgical procedure. One or more of the image processing filters 116A or 116B are applied to the captured image by the controller 210 before the image is displayed to the clinician on a display 212.
The movement of the master handles 208 may be scaled so that the working ends have a corresponding movement that is different, smaller or larger, than the movement performed by the operating hands of the clinician. The scale factor or gearing ratio may be adjustable so that the operator can control the resolution of the working ends of the surgical instrument(s) 204.
During operation of the surgical system 200, the master handles 208 are operated by a clinician to produce a corresponding movement of the robotic arms 206 and/or surgical instruments 204. The master handles 208 provide a signal to the controller 208 which then provides a corresponding signal to one or more drive motors 214. The one or more drive motors 214 are coupled to the robotic arms 206 in order to move the robotic arms 206 and/or surgical instruments 204.
The master handles 208 may include various haptics 216 to provide feedback to the clinician relating to various tissue parameters or conditions, e.g., tissue resistance due to manipulation, cutting or otherwise treating, pressure by the instrument onto the tissue, tissue temperature, tissue impedance, etc. As can be appreciated, such haptics 216 provide the clinician with enhanced tactile feedback simulating actual operating conditions. The haptics 216 may include vibratory motors, electroactive polymers, piezoelectric devices, electrostatic devices, subsonic audio wave surface actuation devices, reverse-electrovibration, or any other device capable of providing a tactile feedback to a user. The master handles 208 may also include a variety of different actuators 218 for delicate tissue manipulation or treatment further enhancing the clinician's ability to mimic actual operating conditions.
The embodiments disclosed herein are examples of the disclosure and may be embodied in various forms. Specific structural and functional details disclosed herein are not to be interpreted as limiting, but as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present disclosure in virtually any appropriately detailed structure. Like reference numerals may refer to similar or identical elements throughout the description of the figures.
The phrases “in an embodiment,” “in embodiments,” “in some embodiments,” or “in other embodiments,” which may each refer to one or more of the same or different embodiments in accordance with the present disclosure. A phrase in the form “A or B” means “(A), (B), or (A and B)”. A phrase in the form “at least one of A, B, or C” means “(A), (B), (C), (A and B), (A and C), (B and C), or (A, B and C)”. A clinician may refers to a clinician or any medical professional, such as a doctor, nurse, technician, medical assistant, or the like) performing a medical procedure.
The systems described herein may also utilize one or more controllers to receive various information and transform the received information to generate an output. The controller may include any type of computing device, computational circuit, or any type of processor or processing circuit capable of executing a series of instructions that are stored in a memory. The controller may include multiple processors and/or multicore central processing units (CPUs) and may include any type of processor, such as a microprocessor, digital signal processor, microcontroller, or the like. The controller may also include a memory to store data and/or algorithms to perform a series of instructions.
Any of the herein described methods, programs, algorithms or codes may be converted to, or expressed in, a programming language or computer program. A “Programming Language” and “Computer Program” includes any language used to specify instructions to a computer, and includes (but is not limited to) these languages and their derivatives: Assembler, Basic, Batch files, BCPL, C, C #, C++, Delphi, Fortran, Java, JavaScript, Machine code, operating system command languages, Pascal, Perl, PL1, Python, scripting languages, Visual Basic, metalanguages which themselves specify programs, and all first, second, third, fourth, and fifth generation computer languages. Also included are database and other data schemas, and any other meta-languages. No distinction is made between languages which are interpreted, compiled, or use both compiled and interpreted approaches. No distinction is also made between compiled and source versions of a program. Thus, reference to a program, where the programming language could exist in more than one state (such as source, compiled, object, or linked) is a reference to any and all such states. Reference to a program may encompass the actual instructions and/or the intent of those instructions.
Any of the herein described methods, programs, algorithms or codes may be contained on one or more machine-readable media or memory. The term “memory” may include a mechanism that provides (e.g., stores and/or transmits) information in a form readable by a machine such a processor, computer, or a digital processing device. For example, a memory may include a read only memory (ROM), random access memory (RAM), magnetic disk storage media, optical storage media, flash memory devices, or any other volatile or non-volatile memory storage device. Code or instructions contained thereon can be represented by carrier wave signals, infrared signals, digital signals, and by other like signals.
It should be understood that the foregoing description is only illustrative of the present disclosure. Various alternatives and modifications can be devised by those skilled in the art without departing from the disclosure. For instance, any of the augmented images described herein can be combined into a single augmented image to be displayed to a clinician. Accordingly, the present disclosure is intended to embrace all such alternatives, modifications and variances. The embodiments described with reference to the attached drawing figs. are presented only to demonstrate certain examples of the disclosure. Other elements, steps, methods and techniques that are insubstantially different from those described above and/or in the appended claims are also intended to be within the scope of the disclosure.
This application is a Continuation Application claiming the benefit of and priority to U.S. patent application Ser. No. 15/768,150, filed Apr. 13, 2018, which is a U.S. National Stage Application filed under 35 U.S.C. § 371(a) of International Patent Application Serial No. PCT/US2016/057797, filed Oct. 20, 2016, which claims the benefit of and priority to U.S. Provisional Patent Application Ser. No. 62/245,526, filed Oct. 23, 2015, the entire disclosure of which is incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
6132368 | Cooper | Oct 2000 | A |
6206903 | Ramans | Mar 2001 | B1 |
6246200 | Blumenkranz et al. | Jun 2001 | B1 |
6312435 | Wallace et al. | Nov 2001 | B1 |
6331181 | Tierney et al. | Dec 2001 | B1 |
6394998 | Wallace et al. | May 2002 | B1 |
6424885 | Niemeyer et al. | Jul 2002 | B1 |
6441577 | Blumenkranz et al. | Aug 2002 | B2 |
6459926 | Nowlin et al. | Oct 2002 | B1 |
6491691 | Morley et al. | Dec 2002 | B1 |
6491701 | Tierney et al. | Dec 2002 | B2 |
6493608 | Niemeyer | Dec 2002 | B1 |
6565554 | Niemeyer | May 2003 | B1 |
6645196 | Nixon et al. | Nov 2003 | B1 |
6659939 | Moll et al. | Dec 2003 | B2 |
6671581 | Niemeyer et al. | Dec 2003 | B2 |
6676684 | Morley et al. | Jan 2004 | B1 |
6685698 | Morley et al. | Feb 2004 | B2 |
6699235 | Wallace et al. | Mar 2004 | B2 |
6714839 | Salisbury, Jr et al. | Mar 2004 | B2 |
6716233 | Whitman | Apr 2004 | B1 |
6728599 | Wang et al. | Apr 2004 | B2 |
6746443 | Morley et al. | Jun 2004 | B1 |
6766204 | Niemeyer et al. | Jul 2004 | B2 |
6770081 | Cooper et al. | Aug 2004 | B1 |
6772053 | Niemeyer | Aug 2004 | B2 |
6783524 | Anderson et al. | Aug 2004 | B2 |
6793652 | Whitman et al. | Sep 2004 | B1 |
6793653 | Sanchez et al. | Sep 2004 | B2 |
6799065 | Niemeyer | Sep 2004 | B1 |
6837883 | Moll et al. | Jan 2005 | B2 |
6839612 | Sanchez et al. | Jan 2005 | B2 |
6840938 | Morley et al. | Jan 2005 | B1 |
6843403 | Whitman | Jan 2005 | B2 |
6846309 | Whitman et al. | Jan 2005 | B2 |
6866671 | Tierney et al. | Mar 2005 | B2 |
6871117 | Wang et al. | Mar 2005 | B2 |
6879880 | Nowlin et al. | Apr 2005 | B2 |
6899705 | Niemeyer | May 2005 | B2 |
6902560 | Morley et al. | Jun 2005 | B1 |
6936042 | Wallace et al. | Aug 2005 | B2 |
6951535 | Ghodoussi et al. | Oct 2005 | B2 |
6974449 | Niemeyer | Dec 2005 | B2 |
6991627 | Madhani et al. | Jan 2006 | B2 |
6994708 | Manzo | Feb 2006 | B2 |
7048745 | Tierney et al. | May 2006 | B2 |
7066926 | Wallace et al. | Jun 2006 | B2 |
7118582 | Wang et al. | Oct 2006 | B1 |
7125403 | Julian et al. | Oct 2006 | B2 |
7155315 | Niemeyer et al. | Dec 2006 | B2 |
7239940 | Wang et al. | Jul 2007 | B2 |
7306597 | Manzo | Dec 2007 | B2 |
7357774 | Cooper | Apr 2008 | B2 |
7373219 | Nowlin et al. | May 2008 | B2 |
7379790 | Toth et al. | May 2008 | B2 |
7386365 | Nixon | Jun 2008 | B2 |
7391173 | Schena | Jun 2008 | B2 |
7398707 | Morley et al. | Jul 2008 | B2 |
7413565 | Wang et al. | Aug 2008 | B2 |
7453227 | Prisco et al. | Nov 2008 | B2 |
7524320 | Tierney et al. | Apr 2009 | B2 |
7558618 | Williams | Jul 2009 | B1 |
7574250 | Niemeyer | Aug 2009 | B2 |
7594912 | Cooper et al. | Sep 2009 | B2 |
7607440 | Coste-Maniere et al. | Oct 2009 | B2 |
7666191 | Orban, III et al. | Feb 2010 | B2 |
7682357 | Ghodoussi et al. | Mar 2010 | B2 |
7689320 | Prisco et al. | Mar 2010 | B2 |
7695481 | Wang et al. | Apr 2010 | B2 |
7695485 | Whitman et al. | Apr 2010 | B2 |
7699855 | Anderson et al. | Apr 2010 | B2 |
7713263 | Niemeyer | May 2010 | B2 |
7725214 | Diolaiti | May 2010 | B2 |
7727244 | Orban, III et al. | Jun 2010 | B2 |
7741802 | Prisco et al. | Jun 2010 | B2 |
7756036 | Druke et al. | Jul 2010 | B2 |
7757028 | Druke et al. | Jul 2010 | B2 |
7762825 | Burbank et al. | Jul 2010 | B2 |
7778733 | Nowlin et al. | Aug 2010 | B2 |
7803151 | Whitman | Sep 2010 | B2 |
7806891 | Nowlin et al. | Oct 2010 | B2 |
7819859 | Prisco et al. | Oct 2010 | B2 |
7819885 | Cooper | Oct 2010 | B2 |
7824401 | Manzo et al. | Nov 2010 | B2 |
7835823 | Sillman et al. | Nov 2010 | B2 |
7843158 | Prisco | Nov 2010 | B2 |
7865266 | Moll et al. | Jan 2011 | B2 |
7865269 | Prisco et al. | Jan 2011 | B2 |
7886743 | Cooper et al. | Feb 2011 | B2 |
7899578 | Prisco et al. | Mar 2011 | B2 |
7907166 | Lamprecht et al. | Mar 2011 | B2 |
7935130 | Williams | May 2011 | B2 |
7963913 | Devengenzo et al. | Jun 2011 | B2 |
7983793 | Toth et al. | Jul 2011 | B2 |
8002767 | Sanchez et al. | Aug 2011 | B2 |
8004229 | Nowlin et al. | Aug 2011 | B2 |
8012170 | Whitman et al. | Sep 2011 | B2 |
8054752 | Druke et al. | Nov 2011 | B2 |
8062288 | Cooper et al. | Nov 2011 | B2 |
8079950 | Stern et al. | Dec 2011 | B2 |
8100133 | Mintz et al. | Jan 2012 | B2 |
8108072 | Zhao et al. | Jan 2012 | B2 |
8120301 | Goldberg et al. | Feb 2012 | B2 |
8142447 | Cooper et al. | Mar 2012 | B2 |
8147503 | Zhao et al. | Apr 2012 | B2 |
8151661 | Schena et al. | Apr 2012 | B2 |
8155479 | Hoffman et al. | Apr 2012 | B2 |
8182469 | Anderson et al. | May 2012 | B2 |
8202278 | Orban, III et al. | Jun 2012 | B2 |
8206406 | Orban, III | Jun 2012 | B2 |
8210413 | Whitman et al. | Jul 2012 | B2 |
8216250 | Orban, III et al. | Jul 2012 | B2 |
8220468 | Cooper et al. | Jul 2012 | B2 |
8239170 | Wegerich | Aug 2012 | B2 |
8256319 | Cooper et al. | Sep 2012 | B2 |
8271071 | Maruccio | Sep 2012 | B2 |
8285517 | Sillman et al. | Oct 2012 | B2 |
8315720 | Mohr et al. | Nov 2012 | B2 |
8335590 | Costa et al. | Dec 2012 | B2 |
8347757 | Duval | Jan 2013 | B2 |
8374723 | Zhao et al. | Feb 2013 | B2 |
8418073 | Mohr et al. | Apr 2013 | B2 |
8419717 | Diolaiti et al. | Apr 2013 | B2 |
8423182 | Robinson et al. | Apr 2013 | B2 |
8452447 | Nixon | May 2013 | B2 |
8454585 | Whitman | Jun 2013 | B2 |
8499992 | Whitman et al. | Aug 2013 | B2 |
8508173 | Goldberg et al. | Aug 2013 | B2 |
8528440 | Morley et al. | Sep 2013 | B2 |
8529582 | Devengenzo et al. | Sep 2013 | B2 |
8540748 | Murphy et al. | Sep 2013 | B2 |
8551116 | Julian et al. | Oct 2013 | B2 |
8562594 | Cooper et al. | Oct 2013 | B2 |
8594841 | Zhao et al. | Nov 2013 | B2 |
8597182 | Stein et al. | Dec 2013 | B2 |
8597280 | Cooper et al. | Dec 2013 | B2 |
8600551 | Itkowitz et al. | Dec 2013 | B2 |
8608773 | Tierney et al. | Dec 2013 | B2 |
8620473 | Diolaiti et al. | Dec 2013 | B2 |
8624537 | Nowlin et al. | Jan 2014 | B2 |
8634957 | Toth et al. | Jan 2014 | B2 |
8638056 | Goldberg et al. | Jan 2014 | B2 |
8638057 | Goldberg et al. | Jan 2014 | B2 |
8644988 | Prisco et al. | Feb 2014 | B2 |
8666544 | Moll et al. | Mar 2014 | B2 |
8668638 | Donhowe et al. | Mar 2014 | B2 |
8696685 | Gilboa | Apr 2014 | B2 |
8746252 | McGrogan et al. | Jun 2014 | B2 |
8749189 | Nowlin et al. | Jun 2014 | B2 |
8749190 | Nowlin et al. | Jun 2014 | B2 |
8758352 | Cooper et al. | Jun 2014 | B2 |
8761930 | Nixon | Jun 2014 | B2 |
8768516 | Diolaiti et al. | Jul 2014 | B2 |
8786241 | Nowlin et al. | Jul 2014 | B2 |
8790243 | Cooper et al. | Jul 2014 | B2 |
8808164 | Hoffman et al. | Aug 2014 | B2 |
8816628 | Nowlin et al. | Aug 2014 | B2 |
8821480 | Burbank | Sep 2014 | B2 |
8823308 | Nowlin et al. | Sep 2014 | B2 |
8827989 | Niemeyer | Sep 2014 | B2 |
8838270 | Druke et al. | Sep 2014 | B2 |
8852174 | Burbank | Oct 2014 | B2 |
8858547 | Brogna | Oct 2014 | B2 |
8862268 | Robinson et al. | Oct 2014 | B2 |
8864751 | Prisco et al. | Oct 2014 | B2 |
8864752 | Diolaiti et al. | Oct 2014 | B2 |
8903546 | Diolaiti et al. | Dec 2014 | B2 |
8903549 | Itkowitz et al. | Dec 2014 | B2 |
8911428 | Cooper et al. | Dec 2014 | B2 |
8912746 | Reid et al. | Dec 2014 | B2 |
8944070 | Guthart et al. | Feb 2015 | B2 |
8989903 | Weir et al. | Mar 2015 | B2 |
9002518 | Manzo et al. | Apr 2015 | B2 |
9014856 | Manzo et al. | Apr 2015 | B2 |
9016540 | Whitman et al. | Apr 2015 | B2 |
9019345 | Patrick | Apr 2015 | B2 |
9043027 | Durant et al. | May 2015 | B2 |
9050120 | Swarup et al. | Jun 2015 | B2 |
9055961 | Manzo et al. | Jun 2015 | B2 |
9068628 | Solomon et al. | Jun 2015 | B2 |
9078684 | Williams | Jul 2015 | B2 |
9084623 | Gomez et al. | Jul 2015 | B2 |
9095362 | Dachs, II et al. | Aug 2015 | B2 |
9096033 | Holop et al. | Aug 2015 | B2 |
9101381 | Burbank et al. | Aug 2015 | B2 |
9113877 | Whitman et al. | Aug 2015 | B1 |
9138284 | Krom et al. | Sep 2015 | B2 |
9144456 | Rosa et al. | Sep 2015 | B2 |
9198730 | Prisco et al. | Dec 2015 | B2 |
9204923 | Manzo et al. | Dec 2015 | B2 |
9226648 | Saadat et al. | Jan 2016 | B2 |
9226750 | Weir et al. | Jan 2016 | B2 |
9226761 | Burbank | Jan 2016 | B2 |
9232984 | Guthart et al. | Jan 2016 | B2 |
9241766 | Duque et al. | Jan 2016 | B2 |
9241767 | Prisco et al. | Jan 2016 | B2 |
9241769 | Larkin et al. | Jan 2016 | B2 |
9259275 | Burbank | Feb 2016 | B2 |
9259277 | Rogers et al. | Feb 2016 | B2 |
9259281 | Griffiths et al. | Feb 2016 | B2 |
9259282 | Azizian et al. | Feb 2016 | B2 |
9261172 | Solomon et al. | Feb 2016 | B2 |
9265567 | Orban, III et al. | Feb 2016 | B2 |
9265584 | Itkowitz et al. | Feb 2016 | B2 |
9283049 | Diolaiti et al. | Mar 2016 | B2 |
9301811 | Goldberg et al. | Apr 2016 | B2 |
9314307 | Richmond et al. | Apr 2016 | B2 |
9317651 | Nixon | Apr 2016 | B2 |
9345546 | Toth et al. | May 2016 | B2 |
9393017 | Flanagan et al. | Jul 2016 | B2 |
9402689 | Prisco et al. | Aug 2016 | B2 |
9417621 | Diolaiti et al. | Aug 2016 | B2 |
9424303 | Hoffman et al. | Aug 2016 | B2 |
9433418 | Whitman et al. | Sep 2016 | B2 |
9446517 | Burns et al. | Sep 2016 | B2 |
9452020 | Griffiths et al. | Sep 2016 | B2 |
9474569 | Manzo et al. | Oct 2016 | B2 |
9480533 | Devengenzo et al. | Nov 2016 | B2 |
9503713 | Zhao et al. | Nov 2016 | B2 |
9550300 | Danitz et al. | Jan 2017 | B2 |
9554859 | Nowlin et al. | Jan 2017 | B2 |
9566124 | Prisco et al. | Feb 2017 | B2 |
9579164 | Itkowitz et al. | Feb 2017 | B2 |
9585641 | Cooper et al. | Mar 2017 | B2 |
9615883 | Schena et al. | Apr 2017 | B2 |
9623563 | Nixon | Apr 2017 | B2 |
9623902 | Griffiths et al. | Apr 2017 | B2 |
9629520 | Diolaiti | Apr 2017 | B2 |
9662177 | Weir et al. | May 2017 | B2 |
9664262 | Donlon et al. | May 2017 | B2 |
9687312 | Dachs, II et al. | Jun 2017 | B2 |
9700334 | Hinman et al. | Jul 2017 | B2 |
9718190 | Larkin et al. | Aug 2017 | B2 |
9730719 | Brisson et al. | Aug 2017 | B2 |
9737199 | Pistor et al. | Aug 2017 | B2 |
9795446 | DiMaio et al. | Oct 2017 | B2 |
9797484 | Solomon et al. | Oct 2017 | B2 |
9801690 | Larkin et al. | Oct 2017 | B2 |
9814530 | Weir et al. | Nov 2017 | B2 |
9814536 | Goldberg et al. | Nov 2017 | B2 |
9814537 | Itkowitz et al. | Nov 2017 | B2 |
9820823 | Richmond et al. | Nov 2017 | B2 |
9827059 | Robinson et al. | Nov 2017 | B2 |
9830371 | Hoffman et al. | Nov 2017 | B2 |
9839481 | Blumenkranz et al. | Dec 2017 | B2 |
9839487 | Dachs, II | Dec 2017 | B2 |
9850994 | Schena | Dec 2017 | B2 |
9855102 | Blumenkranz | Jan 2018 | B2 |
9855107 | Labonville et al. | Jan 2018 | B2 |
9872737 | Nixon | Jan 2018 | B2 |
9877718 | Weir et al. | Jan 2018 | B2 |
9883920 | Blumenkranz | Feb 2018 | B2 |
9888974 | Niemeyer | Feb 2018 | B2 |
9895813 | Blumenkranz et al. | Feb 2018 | B2 |
9901408 | Larkin | Feb 2018 | B2 |
9918800 | Itkowitz et al. | Mar 2018 | B2 |
9943375 | Blumenkranz et al. | Apr 2018 | B2 |
9948852 | Lilagan et al. | Apr 2018 | B2 |
9949798 | Weir | Apr 2018 | B2 |
9949802 | Cooper | Apr 2018 | B2 |
9952107 | Blumenkranz et al. | Apr 2018 | B2 |
9956044 | Gomez et al. | May 2018 | B2 |
9980778 | Ohline et al. | May 2018 | B2 |
10008017 | Itkowitz et al. | Jun 2018 | B2 |
10028793 | Griffiths et al. | Jul 2018 | B2 |
10033308 | Chaghajerdi et al. | Jul 2018 | B2 |
10034719 | Richmond et al. | Jul 2018 | B2 |
10052167 | Au et al. | Aug 2018 | B2 |
10085811 | Weir et al. | Oct 2018 | B2 |
10092344 | Mohr et al. | Oct 2018 | B2 |
10123844 | Nowlin et al. | Nov 2018 | B2 |
10188471 | Brisson | Jan 2019 | B2 |
10201390 | Swarup et al. | Feb 2019 | B2 |
10213202 | Flanagan et al. | Feb 2019 | B2 |
10258416 | Mintz et al. | Apr 2019 | B2 |
10278782 | Jarc et al. | May 2019 | B2 |
10278783 | Itkowitz et al. | May 2019 | B2 |
10282881 | Itkowitz et al. | May 2019 | B2 |
10335242 | Devengenzo et al. | Jul 2019 | B2 |
10405934 | Prisco et al. | Sep 2019 | B2 |
10433922 | Itkowitz et al. | Oct 2019 | B2 |
10464219 | Robinson et al. | Nov 2019 | B2 |
10485621 | Morrissette et al. | Nov 2019 | B2 |
10500004 | Hanuschik et al. | Dec 2019 | B2 |
10500005 | Weir et al. | Dec 2019 | B2 |
10500007 | Richmond et al. | Dec 2019 | B2 |
10507066 | DiMaio et al. | Dec 2019 | B2 |
10510267 | Jarc et al. | Dec 2019 | B2 |
10524871 | Liao | Jan 2020 | B2 |
10548459 | Itkowitz et al. | Feb 2020 | B2 |
10575909 | Robinson et al. | Mar 2020 | B2 |
10592529 | Hoffman et al. | Mar 2020 | B2 |
10595946 | Nixon | Mar 2020 | B2 |
10881469 | Robinson | Jan 2021 | B2 |
10881473 | Itkowitz et al. | Jan 2021 | B2 |
10898188 | Burbank | Jan 2021 | B2 |
10898189 | McDonald, II | Jan 2021 | B2 |
10905506 | Itkowitz et al. | Feb 2021 | B2 |
10912449 | Meglan et al. | Feb 2021 | B2 |
10912544 | Brisson et al. | Feb 2021 | B2 |
10912619 | Jarc et al. | Feb 2021 | B2 |
10918387 | Duque et al. | Feb 2021 | B2 |
10918449 | Solomon et al. | Feb 2021 | B2 |
10932873 | Griffiths et al. | Mar 2021 | B2 |
10932877 | Devengenzo et al. | Mar 2021 | B2 |
20070055128 | Glossop | Mar 2007 | A1 |
20100158330 | Guissin | Jun 2010 | A1 |
20130035581 | Vesto | Feb 2013 | A1 |
20130038707 | Cunningham et al. | Feb 2013 | A1 |
20140213849 | Pandey | Jul 2014 | A1 |
20140275760 | Lee et al. | Sep 2014 | A1 |
20150257653 | Hyde | Sep 2015 | A1 |
20170202633 | Liu | Jul 2017 | A1 |
Entry |
---|
Extended European Search Report dated Jun. 14, 2021 corresponding to counterpart Patent Application EP 21172585.8. |
European Office Action dated Mar. 6, 2020 corresponding to counterpart Patent Application EP 16858177.5. |
International Search Report and Written Opinion of Int'l Appln. PCT/US16/057797 dated Feb. 1, 2017. |
Extended European Search Report dated May 23, 2019 corresponding to counterpart Patent Application EP 16858177.5. |
Number | Date | Country | |
---|---|---|---|
20210145259 A1 | May 2021 | US |
Number | Date | Country | |
---|---|---|---|
62245526 | Oct 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15768150 | US | |
Child | 17143243 | US |